Masutani et al. demonstrated that cell lines from xeroderma pigmentosum variant (XP-V) patients had mutations in POLH and that a recombinant human Pol η protein corrected the UV-lesion translesion synthesis (TLS) defect present in XP-V cell extracts. Here, POLH is linked to Xeroderma pigmentosum variant.